Developing new tools for sensing biological processes to improve health.
Official title: Watson Phase I COBRE Admin Core
Funded at University of Delaware · NIH-11018374 · Data updated 2026-11-12
This study is all about developing new tools to help detect important biological processes in the body, which can lead to better understanding and treatment of diseases, and it's designed for researchers who want to grow their careers while making a positive impact on health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | June 1, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $466,887 |
| NIH project number | 1P20GM156674-01 |
| Project ID | NIH-11018374 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with a variety of human diseases that could benefit from improved biochemical sensing technologies would be ideal candidates.
✕Less likely to help
Patients with conditions that do not involve biochemical or biological processes may not receive direct benefits from this research.
What this research studies
This research focuses on creating innovative mechanisms and tools that can detect biochemical and biological processes, which are crucial for understanding and treating various human diseases. A team of experts from multiple scientific fields, including biology, biochemistry, and biomedical engineering, will collaborate to enhance the capabilities of these sensing technologies. The project also emphasizes mentoring and career development for researchers involved, ensuring that the scientific community grows and thrives. By improving the administrative and scientific operations of the center, the research aims to maximize its impact on health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to advanced diagnostic tools that improve disease detection and treatment.
How similar studies have gone: Other research initiatives in the field of biomedical engineering and biochemical sensing have shown promising results, indicating a strong potential for success in this area.
Where this research is happening
-
University of Delaware
Newark, United States Active
Researchers
- Principal investigator: Watson, Donald Allen — University of Delaware
- Study coordinator: Watson, Donald Allen
Related research
Other NIH-funded projects on the same topics.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
-
New thin, flexible tactile displays to make screens accessible for people who are blind
A new thin film technology will let touch-based screens mimic visual displays, helping people who are blind or visually impaired use phones and other devices.
-
Spinal muscle targets to improve mobility after leg amputation
A study with adults who’ve had a lower-leg amputation will look at how spinal muscle weakness and fat in the back muscles relate to mobility, with the aim of guiding rehabilitation choices.
-
Understanding how tiny cell messengers move in 3-D tissues to improve diagnostics
Researchers are studying how extracellular vesicles, tiny particles that carry disease signals, travel through gel-like tissues to improve noninvasive diagnostic tests.
-
Center for Multiscale Biomolecular Sensing: New Equipment to Probe Disease Signals
A university center is getting equipment support to better measure chemical and biological signals across cells and tissues, with potential benefits for Alzheimer's, autoimmune diseases, and related conditions.
-
Delaware INBRE: Building Delaware’s Biomedical Research Network
A statewide program supports undergraduates and researchers in Delaware to grow biomedical knowledge and train the next generation of scientists.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.